Compulsive Sexual Behavior Clinical Trial
— CSBDOfficial title:
Mind-Body Intervention Practice as a Complementary and Integrative Treatment for Compulsive Sexual Behavior Disorder: Randomized Controlled Trial
Verified date | February 2024 |
Source | University of Sao Paulo General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Mind-body intervention as a complementary and integrative treatment for compulsive sexual behavior disorder. The hypothesis is that participants with CSBD, after being submitted to the protocol of the mind-body intervention group in relation to those submitted to the intervention protocol Shan of the control group, present less severe sexual compulsiveness.
Status | Enrolling by invitation |
Enrollment | 60 |
Est. completion date | September 3, 2025 |
Est. primary completion date | August 15, 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. They must have a minimum score of 28 on the Sexual Compulsiveness Scale (range 10 - 40) or a minimum score of 20 on the Screening Inventory of Hypersexual Disorder (range 0 - 28) and a minimum score of 14 on the Beck Anxiety Inventory (range of 0 - 63); 2. Male; 3. Being Brazilian; 4. Literate in Brazilian Portuguese; 5. Have a satisfactory cognitive level to understand and respond to self-responsive inventories; 6. Have availability to participate in a daily mind-body Intervention program for 12 weeks. Exclusion Criteria: 1. Individuals who meeting the criteria for Substance-Related Disorder and Addictive Disorders (DSM-5, 483); 2. Individuals who meeting the criteria for Paraphilic Disorders (DSM-5, 685); 3. Individuals who meeting the criteria for Gender Dysphoria (DSM-5, 451); 4. Individuals who meeting the criteria for Spectrum of Schizophrenia and other Psychotic Disorders (DSM-5, 87); 5. Individuals who meeting the criteria for Hypomanic or Manic Episode of Mood Disorder (DSM-5, 123); 6. Individuals who meeting the criteria for Neurocognitive Disorders (DSM-5, 591); 7. Individuals who meeting the criteria for Other Mental Disorders (DSM-5, 707); 8. Individuals who have already have practiced kundalini yoga; 9. Individuals who use psychiatric medication and cannot maintain the stability and regularity of the dosage three months before and during the intervention program; 10. Individuals who have attended psychotherapy in the last six months in weekly sessions and with at least 75% attendance; 11. Individuals who have significant spinal problems and / or physical limitations that may interfere with yoga practice, for example, overweight, severe lung and / or cardiovascular disease. |
Country | Name | City | State |
---|---|---|---|
Brazil | Instituto de Psiquiatria do Hospital das Clínicas da Universidade de São Paulo[University of Sao Paulo General Hospital] | São Paulo | SP |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo General Hospital |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sexual Compulsivity Scale (SCS) | Changes in the total score of Sexual Compulsivity Scale, the scores vary between 10 and 40, with the highest ones indicating greater sexual compulsiveness. | Baseline, 4th week, 8th week and 12th week | |
Secondary | Barrat Impulsivity Scale (BIS 11) | Changes in the total score of Barrat Impulsivity Scale, the scores vary between 1 and 30, with the highest ones indicating greater impulsivity. | Baseline, 4th week, 8th week and 12th week | |
Secondary | Hypersexual Disorder Screening Inventory (HDSI) | Changes in the total score of Hypersexual Disorder Screening Inventory score, the scores vary between 0 and 28, with the highest ones indicating greater hypersexuality. | Baseline, 4th week, 8th week and 12th week | |
Secondary | Beck Anxiety Inventory (BAI) | Changes in the total score of Beck Anxiety Inventory, the scores vary between 0 and 63, with the highest ones indicating greater anxiety. | Baseline, 4th week, 8th week and 12th week | |
Secondary | Beck Depression Inventory (BDI) | Changes in the total score of Beck Depression Inventory, the scores vary between 0 and 63, with the highest ones meaning greater depression. | Baseline, 4th week, 8th week and 12th week | |
Secondary | World Health Organization Quality of Life (WHOQOL-bref) | Changes in the total score of World Health Organization Quality of Life-bref, the scores vary from 26 to 130, with the highest ones meaning greater quality of life. | Baseline and 12th week | |
Secondary | Sexual Inhibition Scale (SIS) | Changes in the total score of Sexual Inhibition Scale, the scores are defined as strongly agree, agree, disagree and strongly disagree, the highest scores mean greater sexual inhibition. | Baseline and 12th week | |
Secondary | Sexual Excitation Scale (SES) | Changes in the total score of Sexual Excitation Scale, the scores are defined as strongly agree, agree, disagree and strongly disagree, the highest scores mean greater sexual excitation. | Baseline and 12th week | |
Secondary | International Index of Erectile Function (IIFE) | Changes in IIFE score, the scores are defined as absent, mild, moderate and severe, with the highest ones meaning greater dysfunction. | Baseline and 12th week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00467558 -
Double-Blind Naltrexone in Compulsive Sexual Behavior
|
Phase 2 | |
Recruiting |
NCT06408545 -
Acceptance and Commitment Therapy for Problematic Chemsex
|
N/A | |
Not yet recruiting |
NCT06406296 -
Effectiveness of ACT for Problematic Chemsex
|
N/A | |
Completed |
NCT05572372 -
Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality
|
N/A | |
Completed |
NCT02300051 -
Intervention Study for Individuals With Compulsive Sexual Behavior
|
N/A | |
Completed |
NCT03495414 -
Neurobiological Underpinnings to Hypersexual Disorder
|